45
Participants
Start Date
July 21, 2015
Primary Completion Date
June 16, 2018
Laboratory Biomarker Analysis
Correlative studies
Nivolumab
Given IV
University of Maryland/Greenebaum Cancer Center, Baltimore
Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Moffitt Cancer Center, Tampa
Mayo Clinic Cancer Center P2C, Rochester
Mayo Clinic, Rochester
UC Comprehensive Cancer Center at Silver Cross, New Lenox
Northwestern University, Chicago
University of Chicago Comprehensive Cancer Center, Chicago
Washington University School of Medicine, St Louis
Los Angeles County-USC Medical Center, Los Angeles
USC / Norris Comprehensive Cancer Center, Los Angeles
City of Hope Comprehensive Cancer Center, Duarte
City of Hope South Pasadena, South Pasadena
Keck Medical Center of USC Pasadena, Pasadena
University of California Davis Comprehensive Cancer Center, Sacramento
National University Hospital Singapore, Singapore
National Cancer Centre, Singapore
Johns Hopkins Singapore, Singapore
Chinese University of Hong Kong-Prince of Wales Hospital, Shatin
National Cancer Institute (NCI)
NIH